Dietary Sodium Intake is Predicted By Anti-Hypertensive Medication Regimen in Heart Failure Patients

2.50
Hdl Handle:
http://hdl.handle.net/10755/620263
Category:
Full-text
Type:
Poster
Title:
Dietary Sodium Intake is Predicted By Anti-Hypertensive Medication Regimen in Heart Failure Patients
Author(s):
Smith, Jennifer L.; Lennie, Terry A.; Chung, Misook L.; Mudd-Martin, Gia
Lead Author STTI Affiliation:
Delta Psi
Author Details:
Jennifer L. Smith, RN, jennifer.smith7@uky.edu; Terry A. Lennie, RN, FAHA, FAAN; Misook L. Chung, RN, FAHA, FAAN; Gia Mudd-Martin, MPH, RN
Abstract:
Session presented on Sunday, September 18, 2016: Background: Adherence to low-sodium diet is crucial to heart failure (HF) self-management. Angiotensin converting enzyme inhibitors (ACEi), commonly prescribed to HF patients, decrease salt taste perception and patients taking ACEi may increase dietary sodium intake in response to reduced perception. We hypothesize that HF patients on ACEi will have significantly higher sodium intake, indicated by dietary sodium density. Objective: To examine whether having a prescribed ACEi was associated with increased dietary sodium density. Methods: This was a secondary analysis of baseline data from HF patients in an observational longitudinal study. Dietary sodium intake measured from 4-day food diaries was analyzed with NDS-R software (NRCC, Minneapolis, MN). To control for differences in dietary sodium due to differences in amount of food consumed, dietary sodium density was calculated as 4-day averaged daily sodium intake divided by averaged kilocalories (kcal) consumed. Prescribed medications were ascertained through medical chart review. Patients were categorized into 2 groups: those prescribed and those not prescribed ACEi. We used t-tests to compare sodium intake between ACEi groups. Linear regression was conducted to determine whether prescribed ACEi independently predicted sodium density controlling for age, gender, New York Heart Association (NYHA) Class, and prescribed diuretics and beta blockers. Results: There were 262 HF patients (age 61 � 12, 68% male, 44% NYHA Class III/IV); 76% were prescribed a diuretic, 89% a beta blocker, and 68% an ACEi. Patients prescribed ACEi consumed 13% more sodium per kcal than those not prescribed ACEi (1.8 mg Na/kcal vs. 1.6 mg Na/kcal, p = .001). Prescribed ACEi independently predicted dietary sodium density (beta=.207, p=.002). No confounding factors predicted density. Conclusions: The results support the hypothesis that patients on an ACEi have higher sodium intake. Assessing medication regimen is important for planning interventions to enhance HF patients? adherence to dietary sodium restriction. Research is needed to explore HF patients? salt taste perception to better understand associations between medication regimen and sodium intake.
Keywords:
heart failure; low sodium diet; anti-hypertensive medication
Repository Posting Date:
16-Sep-2016
Date of Publication:
16-Sep-2016
Other Identifiers:
LEAD16PST70
Conference Date:
2016
Conference Name:
Leadership Connection 2016
Conference Host:
Sigma Theta Tau International
Conference Location:
Indianapolis, Indiana, USA
Description:
Leadership Connection 2016 Theme: Personal. Professional. Global. Held at the Marriott Downtown, Indianapolis.

Full metadata record

DC FieldValue Language
dc.language.isoen_USen
dc.type.categoryFull-texten
dc.typePosteren
dc.titleDietary Sodium Intake is Predicted By Anti-Hypertensive Medication Regimen in Heart Failure Patientsen
dc.contributor.authorSmith, Jennifer L.en
dc.contributor.authorLennie, Terry A.en
dc.contributor.authorChung, Misook L.en
dc.contributor.authorMudd-Martin, Giaen
dc.contributor.departmentDelta Psien
dc.author.detailsJennifer L. Smith, RN, jennifer.smith7@uky.edu; Terry A. Lennie, RN, FAHA, FAAN; Misook L. Chung, RN, FAHA, FAAN; Gia Mudd-Martin, MPH, RNen
dc.identifier.urihttp://hdl.handle.net/10755/620263-
dc.description.abstractSession presented on Sunday, September 18, 2016: Background: Adherence to low-sodium diet is crucial to heart failure (HF) self-management. Angiotensin converting enzyme inhibitors (ACEi), commonly prescribed to HF patients, decrease salt taste perception and patients taking ACEi may increase dietary sodium intake in response to reduced perception. We hypothesize that HF patients on ACEi will have significantly higher sodium intake, indicated by dietary sodium density. Objective: To examine whether having a prescribed ACEi was associated with increased dietary sodium density. Methods: This was a secondary analysis of baseline data from HF patients in an observational longitudinal study. Dietary sodium intake measured from 4-day food diaries was analyzed with NDS-R software (NRCC, Minneapolis, MN). To control for differences in dietary sodium due to differences in amount of food consumed, dietary sodium density was calculated as 4-day averaged daily sodium intake divided by averaged kilocalories (kcal) consumed. Prescribed medications were ascertained through medical chart review. Patients were categorized into 2 groups: those prescribed and those not prescribed ACEi. We used t-tests to compare sodium intake between ACEi groups. Linear regression was conducted to determine whether prescribed ACEi independently predicted sodium density controlling for age, gender, New York Heart Association (NYHA) Class, and prescribed diuretics and beta blockers. Results: There were 262 HF patients (age 61 � 12, 68% male, 44% NYHA Class III/IV); 76% were prescribed a diuretic, 89% a beta blocker, and 68% an ACEi. Patients prescribed ACEi consumed 13% more sodium per kcal than those not prescribed ACEi (1.8 mg Na/kcal vs. 1.6 mg Na/kcal, p = .001). Prescribed ACEi independently predicted dietary sodium density (beta=.207, p=.002). No confounding factors predicted density. Conclusions: The results support the hypothesis that patients on an ACEi have higher sodium intake. Assessing medication regimen is important for planning interventions to enhance HF patients? adherence to dietary sodium restriction. Research is needed to explore HF patients? salt taste perception to better understand associations between medication regimen and sodium intake.en
dc.subjectheart failureen
dc.subjectlow sodium dieten
dc.subjectanti-hypertensive medicationen
dc.date.available2016-09-16T14:23:21Z-
dc.date.issued2016-09-16-
dc.date.accessioned2016-09-16T14:23:21Z-
dc.conference.date2016en
dc.conference.nameLeadership Connection 2016en
dc.conference.hostSigma Theta Tau Internationalen
dc.conference.locationIndianapolis, Indiana, USAen
dc.descriptionLeadership Connection 2016 Theme: Personal. Professional. Global. Held at the Marriott Downtown, Indianapolis.en
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.